GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.
Diabetic retinopathy is a severe complication of diabetes that can lead to blindness. The Japanese clinical practice ...
As many as 1.3million people in the UK may unknowingly be living with type 2 diabetes – but there are a few signs to watch ...